1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Neuromodulation Market – By Technology

1.3.2        Neuromodulation Market – By Application

1.3.3        Neuromodulation Market – By End User

1.3.4        South & Central America Neuromodulation Market – By Country

2.           South & Central America Neuromodulation Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America Neuromodulation Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America– PEST Analysis

4.3         Expert Opinion

5.           South & Central America Neuromodulation Market Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Incidence of Neurological Disorders

5.1.2        Growing Developments in Neuromodulation Technology

5.2         Market Restraints

5.2.1        High Cost of Neuromodulation Devices

5.3         Market Opportunities

5.3.1        Rising Demand for Neurostimulation Devices to Treat Chronic Pain

5.4         Future Trends

5.4.1        Technological Advancements

5.5         Impact Analysis

6.           Neuromodulation Market – South & Central America Analysis

6.1         Neuromodulation Market Revenue Forecasts and Analysis

7.           Neuromodulation Market Analysis – By Technology

7.1         Overview

7.2         Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

7.3         External Neuromodulation

7.3.1        Overview

7.3.2        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.3        Respiratory Electrical Stimulation (RES)

7.3.3.1          Overview

7.3.3.2          Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.4        Transcutaneous Electrical Nerve Stimulation (TENS)

7.3.4.1          Overview

7.3.4.2          Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.5        Transcranial Magnetic Stimulation (TMS)

7.3.5.1          Overview

7.3.5.2          Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4         Internal Neuromodulation

7.4.1        Overview

7.4.2        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.3        Deep Brain Stimulation (DBS)

7.4.3.1          Overview

7.4.3.2          Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.4        Sacral Nerve Stimulation (DBS)

7.4.4.1          Overview

7.4.4.2          Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.5        Gastric Electric Stimulation (GES)

7.4.5.1          Overview

7.4.5.2          Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.6        Spinal Cord Stimulation (SCS)

7.4.6.1          Overview

7.4.6.2          Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.7        Vagus Nerve Stimulation (VNS)

7.4.7.1          Overview

7.4.7.2          Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.           Neuromodulation Market Analysis – By Application

8.1         Overview

8.2         Neuromodulation Market Share, by Application, 2019 and 2027 (%)

8.3         Chronic Pain Management

8.3.1        Overview

8.3.2        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.4         Failed Back Syndrome

8.4.1        Overview

8.4.2        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.5         Epilepsy

8.5.1        Overview

8.5.2        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.6         Tremor

8.6.1        Overview

8.6.2        Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.7         Incontinence

8.7.1        Overview

8.7.2        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.8         Depression

8.8.1        Overview

8.8.2        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.9         Dystonia

8.9.1        Overview

8.9.2        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.10      Gastroparesis

8.10.1     Overview

8.10.2     Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.11      Parkinson’s Disease

8.11.1     Overview

8.11.2     Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.12      Obsessive-Compulsive Disorder (OCD)

8.12.1     Overview

8.12.2     Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.13      Migraine

8.13.1     Overview

8.13.2     Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.           Neuromodulation Market Analysis – By End User

9.1         Overview

9.2         Neuromodulation Market Share, by End User, 2019 and 2027, (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Home Healthcare

9.5.1        Overview

9.5.2        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.        Neuromodulation Market – Geographic Analysis

10.1      South & Central America: Neuromodulation Market

10.1.1     Overview

10.1.2     South and Central America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.1.3     South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.1.4     South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.5     South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

10.1.6     South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.1.7     Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.2.1       Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8     Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9     Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1       Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2       Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.1       Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.2       Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3       Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.4       Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.        Impact of COVID-19 Pandemic on South & Central America Neuromodulation Market

11.1      South & Central America: Impact Assessment of COVID-19 Pandemic

12.        Neuromodulation Market – Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      Abbott

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Boston Scientific Corporation

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Medtronic

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      NeuroPace, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      NeuroSigma, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      NEVRO CORP.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Synapse Biomedical Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Soterix Medical Inc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Integer Holdings Corporation

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Magstim

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      Glossary of Terms

Table 1.             South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2.             South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 4.             South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 5.             South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 6.             Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7.             Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 13.          Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Organic Developments Done by Companies

Table 17.          Inorganic Developments Done by Companies

Table 18.          Glossary of Terms, Neuromodulation Market

Figure 1.           South & Central America Neuromodulation Market Segmentation

Figure 2.           South & Central America Neuromodulation Market, By Country

Figure 3.           South & Central America Neuromodulation Market Overview

Figure 4.           Internal Neuromodulation Segment Held Largest Share of Technology Segment in South & Central America Neuromodulation Market

Figure 5.           Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           South & Central America Neuromodulation Market- Leading Country Markets (US$ Mn)

Figure 7.           South & Central America PEST Analysis

Figure 8.           Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 9.           South & Central America Neuromodulation Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 11.        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027  (US$ Million)

Figure 15.        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 22.        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 34.        Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        South and Central America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 38.        South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 39.        South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 40.        Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 43.        Growth Strategies Done by the Companies in the Market, (%)